Literature DB >> 7729918

Role for circulating lipoproteins in protection from endotoxin toxicity.

K R Feingold1, J L Funk, A H Moser, J K Shigenaga, J H Rapp, C Grunfeld.   

Abstract

Previous studies have shown that endotoxin (lipopolysaccharide [LPS])-induced death can be prevented by preincubating LPS with lipoproteins in vitro or by infusing large quantities of lipids into animals prior to LPS administration. In the present study we determined whether physiological levels of lipids also provide protection. Serum lipid levels were decreased by two different mechanisms: administration of 4-aminopyrolo-(3,4-D)pyrimide, which prevents the hepatic secretion of lipoproteins, and administration of pharmacological doses of estradiol, which increases the number of hepatic low-density lipoprotein receptors, leading to increased lipoprotein clearance. In both hypolipidemic models, LPS-induced mortality is markedly increased compared with that of controls with normal serum lipid levels. In both hypolipidemic models, administration of exogenous lipoproteins, which increase levels of serum lipids into the physiological range, reduces the increased mortality to levels similar to that seen in normal animals. In normal lipidemic animals, 63% of 125I-LPS in plasma is associated with lipoproteins, where it would not be capable of stimulating cytokine production. In contrast, in hypolipidemic animals, very little LPS (12 to 17%) is associated with lipoproteins. Rather, more LPS is in the lipoprotein-free plasma compartment, where it could exert biological effects. In both hypolipidemic models, LPS produces a greater increase in serum tumor necrosis factor levels than it does in controls (three- to fivefold increase), and administration of exogenous lipoproteins prevents this increase. Cytokines, in particular tumor necrosis factor, are responsible for most of the toxic effects of LPS. These data provide evidence that physiological levels of serum lipids protect animals from LPS toxicity. Thus, lipoproteins, in addition to playing a role in lipid transport, may have protective functions. Moreover, as part of the immune response, cytokine-induced increases in serum lipid levels may play a role in host defense by decreasing the toxicities of biological and chemical agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729918      PMCID: PMC173262          DOI: 10.1128/iai.63.5.2041-2046.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Antigen-specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins.

Authors:  J C Leong; J P Kane; O Oleszko; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

2.  STUDIES ON FATTY LIVER INDUCTION BY 4-AMINOPYRAZOLOPYRIMIDINE.

Authors:  J F HENDERSON
Journal:  J Lipid Res       Date:  1963-01       Impact factor: 5.922

3.  Identification of the trypanocidal factor in normal human serum: high density lipoprotein.

Authors:  M R Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

4.  The preparation and characterization of a radioiodinated bacterial lipopolysaccharide.

Authors:  R J Ulevitch
Journal:  Immunochemistry       Date:  1978-03

5.  Fate of 51Cr-labeled lipopolysaccharide in tissue culture cells and livers of normal mice.

Authors:  J C Zlydaszyk; R J Moon
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

6.  Studies on the inhibitory activities of human serum lipoproteins for Japanese encephalitis virus.

Authors:  K F Shortridge; W K Ho; A Oya; M Kobayashi
Journal:  Southeast Asian J Trop Med Public Health       Date:  1975-12       Impact factor: 0.267

7.  Effect of estradiol benzoate on lipid metabolism in the rat.

Authors:  M E Fewster; R E Pirrie; D A Turner
Journal:  Endocrinology       Date:  1967-02       Impact factor: 4.736

8.  Lipoprotein and lecithin: cholesterol acyltransferase changes in galactosamine-induced rat liver injury.

Authors:  S M Sabesin; L B Kuiken; J B Ragland
Journal:  Science       Date:  1975-12-26       Impact factor: 47.728

9.  The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.

Authors:  R J Ulevitch; A R Johnston
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

10.  Effects of high sucrose diets and 4-aminopyrazolopyrimidine on serum lipids and lipoproteins in the rat.

Authors:  T S Shiff; P S Roheim; H A Eder
Journal:  J Lipid Res       Date:  1971-09       Impact factor: 5.922

View more
  46 in total

1.  Distribution and kinetics of lipoprotein-bound endotoxin.

Authors:  J H Levels; P R Abraham; A van den Ende; S J van Deventer
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Up-regulation of lipophorin (Lp) and lipophorin receptor (LpR) gene in the mosquito, Culex quinquefasciatus (Diptera: Culicidae), infected with the filarial parasite, Wuchereria bancrofti (Spirurida: Onchocercidae).

Authors:  B A Kumar; K P Paily
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

3.  The role of HDL in innate immunity.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2010-10-13       Impact factor: 5.922

4.  Prepregnancy lipids related to preterm birth risk: the coronary artery risk development in young adults study.

Authors:  Janet M Catov; Roberta B Ness; Melissa F Wellons; David R Jacobs; James M Roberts; Erica P Gunderson
Journal:  J Clin Endocrinol Metab       Date:  2010-05-25       Impact factor: 5.958

5.  Blunting the response to endotoxin in healthy subjects: effects of various doses of intravenous fish oil.

Authors:  Yann K Pittet; Mette M Berger; Thomas-Thi Pluess; Pierre Voirol; Jean-Pierre Revelly; Luc Tappy; René L Chioléro
Journal:  Intensive Care Med       Date:  2009-10-21       Impact factor: 17.440

6.  Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients.

Authors:  Usama Feroze; Kamyar Kalantar-Zadeh; Kevin A Sterling; Miklos Z Molnar; Nazanin Noori; Debbie Benner; Vallabh Shah; Rama Dwivedi; Kenneth Becker; Csaba P Kovesdy; Dominic S Raj
Journal:  J Ren Nutr       Date:  2011-08-31       Impact factor: 3.655

7.  Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats.

Authors:  Zhenghao Zhang; Geeta Datta; Yun Zhang; Andrew P Miller; Paulina Mochon; Yiu-Fai Chen; John Chatham; G M Anantharamaiah; C Roger White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-26       Impact factor: 4.733

8.  HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats.

Authors:  Geeta Datta; Himanshu Gupta; Zhenghao Zhang; Palgunachari Mayakonda; G M Anantharamaiah; C Roger White
Journal:  J Clin Exp Cardiolog       Date:  2011-12-22

Review 9.  A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk.

Authors:  J Bruce German; Robert A Gibson; Ronald M Krauss; Paul Nestel; Benoît Lamarche; Wija A van Staveren; Jan M Steijns; Lisette C P G M de Groot; Adam L Lock; Frédéric Destaillats
Journal:  Eur J Nutr       Date:  2009-03-04       Impact factor: 5.614

10.  Tularemia induces different biochemical responses in BALB/c mice and common voles.

Authors:  Hana Bandouchova; Jana Sedlackova; Miroslav Pohanka; Ladislav Novotny; Martin Hubalek; Frantisek Treml; Frantisek Vitula; Jiri Pikula
Journal:  BMC Infect Dis       Date:  2009-06-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.